Search Results - "Pruszyński, Marek"

Refine Results
  1. 1
  2. 2

    Adsorption of 137Cs on titanate nanostructures by Filipowicz, Barbara, Pruszyński, Marek, Krajewski, Seweryn, Bilewicz, Aleksander

    “…Various types of sodium and potassium titanate nanostructures (nanotubes, nanofibers, nanoribbons, nanwires) were synthesized and characterized by X-ray…”
    Get full text
    Journal Article
  3. 3

    Trastuzumab-Modified Gold Nanoparticles Labeled with 211At as a Prospective Tool for Local Treatment of HER2-Positive Breast Cancer by Dziawer, Łucja, Majkowska-Pilip, Agnieszka, Gaweł, Damian, Godlewska, Marlena, Pruszyński, Marek, Jastrzębski, Jerzy, Wąs, Bogdan, Bilewicz, Aleksander

    Published in Nanomaterials (Basel, Switzerland) (18-04-2019)
    “…Highly localized radiotherapy with radionuclides is a commonly used treatment modality for patients with unresectable solid tumors. Herein, we propose a novel…”
    Get full text
    Journal Article
  4. 4

    Lead(II) complexes with amide-appended tetraazamacrocyclic ligands – Synthesis, structure, characterization and calculation studies by Lyczko, Krzysztof, Lyczko, Monika, Pruszyński, Marek

    Published in Polyhedron (01-12-2020)
    “…Synthesis, structure and characterization of cationic lead(II) complexes with tetraazamacrocyclic ligands containing four amide groups are presented by means…”
    Get full text
    Journal Article
  5. 5

    Design and Evaluation of 223Ra-Labeled and Anti-PSMA Targeted NaA Nanozeolites for Prostate Cancer Therapy–Part I by Czerwińska, Malwina, Fracasso, Giulio, Pruszyński, Marek, Bilewicz, Aleksander, Kruszewski, Marcin, Majkowska-Pilip, Agnieszka, Lankoff, Anna

    Published in Materials (02-09-2020)
    “…Prostate cancer is the second most frequent malignancy in men worldwide. Unfortunately, current therapies often lead to the onset of metastatic…”
    Get full text
    Journal Article
  6. 6

    Crystal Structure, Spectroscopic Characterization, Antioxidant and Cytotoxic Activity of New Mg(II) and Mn(II)/Na(I) Complexes of Isoferulic Acid by Kalinowska, Monika, Gołębiewska, Ewelina, Mazur, Liliana, Lewandowska, Hanna, Pruszyński, Marek, Świderski, Grzegorz, Wyrwas, Marta, Pawluczuk, Natalia, Lewandowski, Włodzimierz

    Published in Materials (11-06-2021)
    “…The Mg(II) and heterometallic Mn(II)/Na(I) complexes of isoferulic acid (3-hydroxy-4-methoxycinnamic acid, IFA) were synthesized and characterized by infrared…”
    Get full text
    Journal Article
  7. 7

    Adsorption of [sup.137]Cs on titanate nanostructures by Filipowicz, Barbara, Pruszynski, Marek, Krajewski, Seweryn, Bilewicz, Aleksander

    “…Various types of sodium and potassium titanate nanostructures (nanotubes, nanofibers, nanoribbons, nanwires) were synthesized and characterized by X-ray…”
    Get full text
    Journal Article
  8. 8

    Fe(III) and Cu(II) Complexes of Chlorogenic Acid: Spectroscopic, Thermal, Anti-/Pro-Oxidant, and Cytotoxic Studies by Kalinowska, Monika, Gryko, Kamila, Gołębiewska, Ewelina, Świderski, Grzegorz, Lewandowska, Hanna, Pruszyński, Marek, Zawadzka, Małgorzata, Kozłowski, Maciej, Sienkiewicz-Gromiuk, Justyna, Lewandowski, Włodzimierz

    Published in Materials (01-10-2022)
    “…Complexes of chlorogenic acid (5-CQA) with copper(II) and iron(III) were synthesized in a solid state and examined by means of FT-IR, thermogravimetric, and…”
    Get full text
    Journal Article
  9. 9

    Trastuzumab-Modified Gold Nanoparticles Labeled with 211 At as a Prospective Tool for Local Treatment of HER2-Positive Breast Cancer by Dziawer, Łucja, Majkowska-Pilip, Agnieszka, Gaweł, Damian, Godlewska, Marlena, Pruszyński, Marek, Jastrzębski, Jerzy, Wąs, Bogdan, Bilewicz, Aleksander

    Published in Nanomaterials (Basel, Switzerland) (18-04-2019)
    “…Highly localized radiotherapy with radionuclides is a commonly used treatment modality for patients with unresectable solid tumors. Herein, we propose a novel…”
    Get full text
    Journal Article
  10. 10

    Astatine-211: production and availability by Zalutsky, Michael R, Pruszynski, Marek

    Published in Current radiopharmaceuticals (01-07-2011)
    “…The 7.2-h half life radiohalogen (211)At offers many potential advantages for targeted α-particle therapy; however, its use for this purpose is constrained by…”
    Get more information
    Journal Article
  11. 11
  12. 12

    Stability and in vivo behavior of Rh[16aneS4 -diol]211 At complex: A potential precursor for astatine radiopharmaceuticals by Pruszyński, Marek, Łyczko, Monika, Bilewicz, Aleksander, Zalutsky, Michael R

    Published in Nuclear medicine and biology (01-05-2015)
    “…Abstract Introduction The heavy halogen211 At is of great interest for targeted radiotherapy because it decays by the emission of short-range, high-energy…”
    Get full text
    Journal Article
  13. 13

    Co(II) Complex of Quercetin–Spectral, Anti-/Pro-Oxidant and Cytotoxic Activity in HaCaT Cell Lines by Kalinowska, Monika, Lewandowska, Hanna, Pruszyński, Marek, Świderski, Grzegorz, Gołębiewska, Ewelina, Gryko, Kamila, Braun, Julia, Borkowska, Monika, Konieczna, Magda, Lewandowski, Włodzimierz

    Published in Applied sciences (01-10-2021)
    “…In this study a cobalt(II) complex of quercetin was synthetized in the solid state with the general formula Co(C15H9O7)2∙2H2O. The FT-IR, elemental analysis,…”
    Get full text
    Journal Article
  14. 14

    Preparation of Rh[16aneS 4 -diol] 211 At and Ir[16aneS 4 -diol] 211 At Complexes as Potential Precursors for Astatine Radiopharmaceuticals. Part I: Synthesis by Pruszyński, Marek, Bilewicz, Aleksander, Zalutsky, Michael R.

    Published in Bioconjugate chemistry (01-04-2008)
    “…The goal of this study was to evaluate a new approach that can be applied for labeling biomolecules with 211 At. Many astatine compounds that have been…”
    Get full text
    Journal Article
  15. 15

    211 At labelled Substance P (5–11) as potential radiopharmaceutical for glioma treatment by Lyczko, Monika, Pruszynski, Marek, Majkowska-Pilip, Agnieszka, Lyczko, Krzysztof, Was, Bogdan, Meczynska-Wielgosz, Sylwia, Kruszewski, Marcin, Szkliniarz, Katarzyna, Jastrzebski, Jerzy, Stolarz, Anna, Bilewicz, Aleksander

    Published in Nuclear medicine and biology (01-10-2017)
    “…Abstract Introduction The purpose of the present work was to label Substance P (5–11) with211 At using a rhodium(III) complex with a bifunctional ligand –…”
    Get full text
    Journal Article
  16. 16

    Stability and in vivo behavior of Rh[16aneS4-diol]211At complex: A potential precursor for astatine radiopharmaceuticals by Pruszyński, Marek, Łyczko, Monika, Bilewicz, Aleksander, Zalutsky, Michael R.

    Published in Nuclear medicine and biology (01-05-2015)
    “…The heavy halogen 211At is of great interest for targeted radiotherapy because it decays by the emission of short-range, high-energy α-particles. However, many…”
    Get full text
    Journal Article
  17. 17

    131I-labeled Anti-HER2 Camelid sdAb as a Theranostic Tool in Cancer Treatment by D'Huyvetter, Matthias, De Vos, Jens, Xavier, Catarina, Pruszynski, Marek, Sterckx, Yann G.J., Massa, Sam, Raes, Geert, Caveliers, Vicky, Zalutsky, Michael R., Lahoutte, Tony, Devoogdt, Nick

    Published in Clinical cancer research (01-11-2017)
    “…Abstract Purpose: Camelid single-domain antibody-fragments (sdAb) have beneficial pharmacokinetic properties, and those targeted to HER2 can be used for…”
    Get full text
    Journal Article
  18. 18

    New measurement of excitation functions for (p,x) reactions on (nat)Mo with special regard to the formation of (95m)Tc, (96m+g)Tc, (99m)Tc and (99)Mo by Lebeda, Ondrej, Pruszyński, Marek

    Published in Applied radiation and isotopes (01-12-2010)
    “…Cross-sections for the proton induced reactions on natural molybdenum leading to (93m)Tc, (93m+g)Tc, (94)Tc, (94m)Tc, (95)Tc, (95m)Tc, (96m+g)Tc, (99m)Tc,…”
    Get full text
    Journal Article
  19. 19
  20. 20